Helderberg Research Institute

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Atrial fibrillation1 trial
• Coronary artery disease1 trial
• High blood pressure1 trial
• Type 2 diabetes1 trial

Phase

• Phase 33 trials

Status

• Active, not recruiting1 trial
• Completed1 trial
• Recruiting1 trial

Lead sponsor

• Janssen Research & Development, LLC2 trials
• Boehringer Ingelheim1 trial

Running trials

• Recruiting

  EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  NCT07064473· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Active, not recruiting

  A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation

  NCT05757869· Phase 3· Janssen Research & Development, LLC· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• High blood pressure1 recruiting
• Type 2 diabetes1 recruiting

Closed trials

• Completed

  A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

  NCT05754957· Phase 3· Janssen Research & Development, LLC· Source